☰

Dedra H. Fagan, Ph.D. - Publications

Affiliations: 
2012 Pharmacology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Fagan DH, Fettig LM, Avdulov S, Beckwith H, Peterson MS, Ho YY, Wang F, Polunovsky VA, Yee D. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation. Hormones & Cancer. PMID 28577281 DOI: 10.1007/S12672-017-0296-3  0.637
2016 Becker MA, Ibrahim YH, Oh AS, Fagan DH, Byron SA, Sarver AL, Lee AV, Shaw LM, Fan C, Perou CM, Yee D. Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer. Plos One. 11: e0150564. PMID 26991655 DOI: 10.1371/Journal.Pone.0150564  0.723
2015 Walter W, Thomalla J, Bruhn J, Fagan DH, Zehowski C, Yee D, Skildum A. Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells. Springerplus. 4: 689. PMID 26576332 DOI: 10.1186/S40064-015-1444-2  0.61
2013 Yang Y, Fagan D, Anderson LF, LaPara K, Zhang X, Ochnik A, Chan JY, Beckwith H, Yee D. Abstract IA17: Targeting downstream effectors of growth factor signaling Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-Ia17  0.714
2012 Fagan DH, Uselman RR, Sachdev D, Yee D. Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment. Cancer Research. 72: 3372-80. PMID 22573715 DOI: 10.1158/0008-5472.Can-12-0684  0.702
2012 Fagan DH, Uselman RR, Sachdev D, Yee D. Expression of type I insulin-like growth factor receptor (IGF1R) in tamoxifen-resistant cells: Implications for cotargeting of IGF1R and estrogen receptor (ER) in breast cancer. Journal of Clinical Oncology. 30: e13590-e13590. DOI: 10.1200/Jco.2012.30.15_Suppl.E13590  0.717
2010 Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, Yee D. Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene. 29: 2517-27. PMID 20154728 DOI: 10.1038/Onc.2010.17  0.726
2009 Yee D, Fagan DH, Zhang X, Oh AS, LaPara K, Becker M, Sachdev D, Zhang H. Abstract CN07-02: Disrupting insulin‐like growth factor signaling with monoclonal antibodies Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-Cn07-02  0.73
2009 Yee D, Zhang X, LaPara K, Fagan D, Ibrahim Y, Zhang H, Zeng X, Becker M, Sachdev D. 58 Inhibition of IGF signalling as cancer therapy European Journal of Cancer Supplements. 7: 17. DOI: 10.1016/S1359-6349(09)70061-8  0.671
2008 Fagan DH, Yee D. Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. Journal of Mammary Gland Biology and Neoplasia. 13: 423-9. PMID 19003523 DOI: 10.1007/S10911-008-9098-0  0.653
Show low-probability matches.